12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Impracor update

Imprimis began a pharmacokinetic trial to compare Impracor vs. an oral dose of ketoprofen in 40 healthy volunteers. The compound has completed a Phase III trial to treat pain associated with mild to moderate acute soft tissue injury. Final data from the trial showed that...

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >